Drug
Nivolumab And Relatlimab-rmbw
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Myocarditis | 19 | 74.7 | 77.7 | signal |
| 2 | Malignant Neoplasm Progression | 34 | 14.8 | 15.9 | signal |
| 3 | Malignant Melanoma | 4 | 13.2 | 13.4 | signal |
| 4 | Product Storage Error | 19 | 9.8 | 10.1 | signal |